2.96
Editas Medicine Inc 주식(EDIT)의 최신 뉴스
Gene Editing Market Exclusive Report with Detailed Study - openPR.com
What is Editas Medicine Inc. company’s growth strategyFree Stock Index Interpretation - jammulinksnews.com
Does Editas Medicine Inc. stock perform well during market downturnsHigh-velocity capital appreciation - jammulinksnews.com
Should I hold or sell Editas Medicine Inc. stock in 2025Identify breakout stocks before they peak - jammulinksnews.com
Editas Medicine (NASDAQ:EDIT) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Why is Editas Medicine Inc. stock attracting strong analyst attentionMaximize returns with smart investment plans - jammulinksnews.com
Is Editas Medicine Inc. stock overvalued or undervaluedUnlock daily market insights for better decisions - jammulinksnews.com
What catalysts could drive Editas Medicine Inc. stock higher in 2025Massive profits - jammulinksnews.com
What drives Editas Medicine Inc. stock priceTriple-digit profit margins - PrintWeekIndia
Will Editas Medicine Inc. stock split in the near futureConsistent triple-digit returns - jammulinksnews.com
Can Editas Medicine Inc. stock recover from recent declineFree Stock Market Forecast Reports - jammulinksnews.com
What analysts say about Editas Medicine Inc. stockBreakout stock performance - Autocar Professional
What drives Avanos Medical Inc. stock priceExplosive market performance - jammulinksnews.com
Editas Medicine Inc. Stock Analysis and ForecastUnrivaled growth potential - jammulinksnews.com
Is Editas Medicine Inc. a good long term investmentExceptional profit margins - Autocar Professional
There's Reason For Concern Over Editas Medicine, Inc.'s (NASDAQ:EDIT) Massive 42% Price Jump - simplywall.st
What makes Editas Medicine Inc. stock price move sharplyVerified Return Tips - beatles.ru
Editas Medicine, Inc. (NASDAQ:EDIT) Receives Average Rating of "Hold" from Brokerages - MarketBeat
Numerous Editas Medicine Insiders Sold Stock: Not A Positive Omen - simplywall.st
Crispr Genomic Cure Market in 2032: A Glimpse Into the Future - openPR.com
Editas Medicine (EDIT) Soars 7.69% on Positive Data - AInvest
Cathie Wood shells out $13.9 million for one high-stakes biotech stock - Yahoo Finance
Editas Surpasses Therapeutic Gene Editing Threshold in New Preclinical Data - MSN
Restore Health – Therapies that cureTelethon - Ricerca Malattie Genetiche Rare
Editas Medicine, Inc.(NasdaqGS: EDIT) added to Russell 3000E Index - MarketScreener
Top 10 CRISPR Stocks to Buy Now - Insider Monkey
Wall Street Expects Editas Medicine to Soar 53%. Is It Time to Buy Now? - The Motley Fool
자본화:
|
볼륨(24시간):